ConductScience.org, home

Gene · 6283

Papers3,572

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Development of immune-derived molecular markers for coronary heart disease via multimachine learning.iScience202641782820PubTator, text miningPubMed
Integrating multimodal intelligence in heart failure: AI-driven risk prediction, precision diagnosis, phenotyping, personalized treatment, and prognosis.Chin Med J (Engl)202641782204PubTator, text miningPubMed
Genetic association between PCSK9 and coronary artery calcification mediated by inflammatory cytokines.Front Cardiovasc Med202641778065PubTator, text miningPubMed
Identification of potential biomarkers related to the Bitong mixture in osteoarthritis based on bioinformatics and network pharmacology, and exploration of the mechanism involved.Front Immunol202641766874PubTator, text miningPubMed
Novel advances in juvenile idiopathic arthritis associated uveitis.Arthritis Res Ther202641761332PubTator, text miningPubMed
A Reproducible Ceramide Phenotype of Sepsis Across Aetiologies - A Monocenter Cohort Study.J Inflamm Res202641757278PubTator, text miningPubMed
The Role of APOL1 in Necrotizing Enterocolitis and Its Promise as a Diagnostic Biomarker.Mediators Inflamm202641743217PubTator, text miningPubMed
Assessing Targeted Proteomics in Inflammatory Skin Diseases with the Tape-stripping Method.Acta Derm Venereol202641725456PubTator, text miningPubMed
Platelets as immune sensors: monitoring immune dynamics and diagnosing disease states across multiple disorders.EBioMedicine202641719795PubTator, text miningPubMed
Research progress on macrophage regulation of atherosclerosis.Front Cardiovasc Med202641717578PubTator, text miningPubMed
Extended treatment of abrocitinib: evaluation of efficacy and safety in chronic actinic dermatitis.Front Med (Lausanne)202641716804PubTator, text miningPubMed
Serum Calprotectin in Hospitalized Patients with COVID-19 in Relation to High-Dimensional Serum Proteomic Patterns.Int J Mol Sci202641683670PubTator, text miningPubMed
Unveiling the therapeutic potential of Resveratrol against neutrophil-mediated hyperinflammation in sepsis: An in-silico, molecular docking, and ex-vivo approach.Biochem Biophys Res Commun202641666610PubTator, text miningPubMed
S100A12 drives inflammatory and metabolic reprogramming in sepsis-associated acute kidney injury.Front Mol Biosci202641657733PubTator, text miningPubMed
Electroacupuncture alleviates migraine through CXCL13/CXCR5-mediated communication.Chin Med202641630047PubTator, text miningPubMed
CAMK1D and PI3 in low-density neutrophils are associated with the anti-hypertensive effects of valsartan.Eur J Pharmacol202641628662PubTator, text miningPubMed
Elevated acute-phase plasma levels of S100A12 [EN-RAGE] are associated with vascular recurrence after ischemic stroke.Eur Stroke J202641614460PubTator, text miningPubMed
Preventing surgery-induced natural killer cell suppression and metastases by inhibiting PI3K-gamma signaling in myeloid-derived suppressor cells.J Immunother Cancer202641611243PubTator, text miningPubMed
Identification of potential diagnostic biomarkers for systemic juvenile idiopathic arthritis by integrative transcriptomic analysis.Autoimmunity202641579068PubTator, text miningPubMed
Integrated single cell RNA sequencing and flow cytometry analysis identifies elevated S100A6+ and S100A8+ myeloid subsets in pancreatic ductal adenocarcinoma.Clin Immunol202641577159PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/6283/papers?page=4